Evidence map›Paper›PMID 27104063›Full record

ArticleJournal of Alzheimer's disease & Parkinsonism2016

The Role of Upregulated APOE in Alzheimer's Disease Etiology.

William K Gottschalk, Mirta Mihovilovic, Allen D Roses, Ornit Chiba-Falek

Open access · hybridAbstract read
In one paragraph

Article in Journal of Alzheimer's disease & Parkinsonism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein.International journal of molecular sciences · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. International journal of molecular sciences · 2021
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

William K GottschalkDepartment of Neurology, Duke University Medical Center, Durham, NC 27710, USA.
Mirta MihovilovicDepartment of Neurology, Duke University Medical Center, Durham, NC 27710, USA.
Allen D RosesDepartment of Neurology, Duke University Medical Center, Durham, NC 27710, USA; Zinfandel Pharmaceuticals, Chapel Hill, NC, USA.
Ornit Chiba-FalekDepartment of Neurology, Duke University Medical Center, Durham, NC 27710, USA; Center for Genomic and Computational Biology, Duke University Medical Center, Durham, NC 27710, USA.
Duke Medical Center · USDuke University Hospital · US

Funding

Role of the TOMM40 poly-T variant in the pathogenesis of Alzheimer's diseaseR01AG040370 · NIA · DUKE UNIVERSITY · PI CHIBA-FALEK, ORNIT · 2013 to 2017
$2.2M
NIA NIH HHS R01 AG040370
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27104063
PMCPMC4836841
OpenAlexW2416759546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.